Your search returned 99 results.

Results
	81.	A multistate outbreak of infections caused by Yersinia enterocolitica transmitted by pasteurized milk. [electronic resource] by Tacket, C O Narain, J P Sattin, R Lofgren, J P Konigsberg, C Rendtorff, R C Rausa, A Davis, B R Cohen, M L Producer: 19840222 In: JAMA vol. 251 Availability: No items available. Save to lists Add to cart (remove)
	82.	Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers. [electronic resource] by Tacket, C O Hone, D M Curtiss, R Kelly, S M Losonsky, G Guers, L Harris, A M Edelman, R Levine, M M Producer: 19920218 In: Infection and immunity vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	83.	Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae. [electronic resource] by Tacket, C O Losonsky, G Nataro, J P Cryz, S J Edelman, R Fasano, A Michalski, J Kaper, J B Levine, M M Producer: 19931228 In: The Journal of infectious diseases vol. 168 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	84.	Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity. [electronic resource] by Losonsky, G A Lim, Y Motamedi, P Comstock, L E Johnson, J A Morris, J G Tacket, C O Kaper, J B Levine, M M Producer: 19970718 In: Clinical and diagnostic laboratory immunology vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	85.	Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. [electronic resource] by Tacket, C O Sztein, M B Losonsky, G A Wasserman, S S Nataro, J P Edelman, R Pickard, D Dougan, G Chatfield, S N Levine, M M Producer: 19970221 In: Infection and immunity vol. 65 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	86.	A voluntary serosurvey and behavioral risk assessment for human immunodeficiency virus infection among college students. [electronic resource] by Kotloff, K L Tacket, C O Wasserman, S S Bridwell, M W Cowan, J E Clemens, J D Brothers, T A O'Donnell, S A Quinn, T C Producer: 19920227 In: Sexually transmitted diseases vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	87.	Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection. [electronic resource] by Clerici, M Tacket, C O Via, C S Lucey, D R Muluk, S C Zajac, R A Boswell, R N Berzofsky, J A Shearer, G M Producer: 19910715 In: European journal of immunology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	88.	Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C. [electronic resource] by Tacket, C O Galen, J Sztein, M B Losonsky, G Wyant, T L Nataro, J Wasserman, S S Edelman, R Chatfield, S Dougan, G Levine, M M Producer: 20001207 In: Clinical immunology (Orlando, Fla.) vol. 97 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	89.	Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative. [electronic resource] by Bartlett, J A Wasserman, S S Hicks, C B Dodge, R T Weinhold, K J Tacket, C O Ketter, N Wittek, A E Palker, T J Haynes, B F Producer: 19981105 In: AIDS (London, England) vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	90.	The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. [electronic resource] by Dolin, R Graham, B S Greenberg, S B Tacket, C O Belshe, R B Midthun, K Clements, M L Gorse, G J Horgan, B W Atmar, R L Producer: 19910118 In: Annals of internal medicine vol. 114 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	91.	Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru. [electronic resource] by Taylor, D N Tacket, C O Losonsky, G Castro, O Gutierrez, J Meza, R Nataro, J P Kaper, J B Wasserman, S S Edelman, R Levine, M M Cryz, S J Producer: 19970919 In: Infection and immunity vol. 65 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	92.	Role of EspB in experimental human enteropathogenic Escherichia coli infection. [electronic resource] by Tacket, C O Sztein, M B Losonsky, G Abe, A Finlay, B B McNamara, B P Fantry, G T James, S P Nataro, J P Levine, M M Donnenberg, M S Producer: 20000623 In: Infection and immunity vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	93.	Expanded safety and immunogenicity of a bivalent, oral, attenuated cholera vaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama. [electronic resource] by Taylor, D N Sanchez, J L Castro, J M Lebron, C Parrado, C M Johnson, D E Tacket, C O Losonsky, G A Wasserman, S S Levine, M M Cryz, S J Producer: 19990426 In: Infection and immunity vol. 67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	94.	Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination. [electronic resource] by Tacket, C O Cohen, M B Wasserman, S S Losonsky, G Livio, S Kotloff, K Edelman, R Kaper, J B Cryz, S J Giannella, R A Schiff, G Levine, M M Producer: 19991220 In: Infection and immunity vol. 67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	95.	Validation of a volunteer model of cholera with frozen bacteria as the challenge. [electronic resource] by Sack, D A Tacket, C O Cohen, M B Sack, R B Losonsky, G A Shimko, J Nataro, J P Edelman, R Levine, M M Giannella, R A Schiff, G Lang, D Producer: 19980514 In: Infection and immunity vol. 66 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	96.	Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. [electronic resource] by Tacket, C O Sztein, M B Wasserman, S S Losonsky, G Kotloff, K L Wyant, T L Nataro, J P Edelman, R Perry, J Bedford, P Brown, D Chatfield, S Dougan, G Levine, M M Producer: 20000316 In: Infection and immunity vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	97.	Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans. [electronic resource] by Gonzalez, C Hone, D Noriega, F R Tacket, C O Davis, J R Losonsky, G Nataro, J P Hoffman, S Malik, A Nardin, E Sztein, M B Heppner, D G Fouts, T R Isibasi, A Levine, M M Producer: 19940418 In: The Journal of infectious diseases vol. 169 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	98.	Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines. [electronic resource] by Kanesa-Thasan, N Edelman, R Tacket, C O Wasserman, S S Vaughn, D W Coster, T S Kim-Ahn, G J Dubois, D R Putnak, J R King, A Summers, P L Innis, B L Eckels, K H Hoke, C H Producer: 20040210 In: The American journal of tropical medicine and hygiene vol. 69 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	99.	Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators. [electronic resource] by Birx, D L Loomis-Price, L D Aronson, N Brundage, J Davis, C Deyton, L Garner, R Gordin, F Henry, D Holloway, W Kerkering, T Luskin-Hawk, R McNeil, J Michael, N Foster Pierce, P Poretz, D Ratto-Kim, S Renzullo, P Ruiz, N Sitz, K Smith, G Tacket, C Thompson, M Tramont, E Yangco, B Yarrish, R Redfield, R R Producer: 20000427 In: The Journal of infectious diseases vol. 181 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5